Thrivent Financial for Lutherans Purchases 104,857 Shares of Danaher Corporation $DHR

Thrivent Financial for Lutherans raised its position in shares of Danaher Corporation (NYSE:DHR) by 13.2% in the fourth quarter, HoldingsChannel reports. The firm owned 900,288 shares of the conglomerate’s stock after acquiring an additional 104,857 shares during the period. Thrivent Financial for Lutherans’ holdings in Danaher were worth $206,103,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Tyche Wealth Partners LLC purchased a new position in shares of Danaher in the 3rd quarter valued at $462,000. Bank Pictet & Cie Europe AG grew its stake in Danaher by 25.4% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after buying an additional 74,301 shares during the last quarter. Lockheed Martin Investment Management Co. grew its stake in Danaher by 49.4% during the 3rd quarter. Lockheed Martin Investment Management Co. now owns 25,340 shares of the conglomerate’s stock worth $5,024,000 after buying an additional 8,380 shares during the last quarter. Johnson Investment Counsel Inc. grew its stake in Danaher by 2.9% during the 3rd quarter. Johnson Investment Counsel Inc. now owns 664,705 shares of the conglomerate’s stock valued at $131,784,000 after purchasing an additional 18,744 shares during the last quarter. Finally, Resona Asset Management Co. Ltd. grew its stake in Danaher by 4.6% during the 3rd quarter. Resona Asset Management Co. Ltd. now owns 513,288 shares of the conglomerate’s stock valued at $100,071,000 after purchasing an additional 22,595 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 10.80% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $164.59 on Friday. The stock has a market capitalization of $116.49 billion, a price-to-earnings ratio of 31.84, a PEG ratio of 2.22 and a beta of 0.81. Danaher Corporation has a twelve month low of $163.32 and a twelve month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The stock has a 50-day moving average of $187.15 and a 200 day moving average of $210.72.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.88 EPS. Sell-side analysts anticipate that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 1.0%. Danaher’s dividend payout ratio is presently 30.95%.

Analysts Set New Price Targets

DHR has been the topic of several research analyst reports. The Goldman Sachs Group dropped their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. KeyCorp reissued an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Finally, JPMorgan Chase & Co. decreased their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Eighteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average price target of $238.65.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.